Carl Engman

Generation of antigen-specific Foxp3+ regulatory T-cells in vivo following administration of diabetes-reversing tolerogenic microspheres does not require provision of antigen in the formulation

Carl Engman, Yi Wen, Wilson S. Meng et al. · Clinical Immunology · 2015 · 65 citations

Autoimmune Disease, Medicine, T-regulatory Cell +9

Retinoic acid-producing,<i>ex-vivo</i>-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes

V Di, Brett E. Phillips, Carl Engman et al. · Clinical & Experimental Immunology · 2013 · 49 citations · Full text

Involvement of Suppressive B-Lymphocytes in the Mechanism of Tolerogenic Dendritic Cell Reversal of Type 1 Diabetes in NOD Mice

Valentina Di, Brett E. Phillips, Carl Engman et al. · PLoS ONE · 2014 · 45 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +20

Interleukin-7 matures suppressive CD127+ forkhead box P3 (FoxP3)+ T cells into CD127- CD25high FoxP3+ regulatory T cells

V Di, Antonella D’Anneo, Brett E. Phillips et al. · Clinical & Experimental Immunology · 2011 · 28 citations · Full text

Arrest in the Progression of Type 1 Diabetes at the Mid-Stage of Insulitic Autoimmunity Using an Autoantigen-Decorated All-trans Retinoic Acid and Transforming Growth Factor Beta-1 Single Microparticle Formulation

Brett E. Phillips, Yésica Garciafigueroa, Carl Engman et al. · Frontiers in Immunology · 2021 · 23 citations · Full text